Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci. (2017)
Attributed to:
A novel vaccine for broad protection against meningococcal disease: progression to phase I clinical trial
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1128/cvi.00430-16
PubMed Identifier: 27847367
Publication URI: http://europepmc.org/abstract/MED/27847367
Type: Journal Article/Review
Volume: 24
Parent Publication: Clinical and vaccine immunology : CVI
Issue: 1
ISSN: 1556-679X